Use for interleukin-33 (il-33) and the il-33 receptor complex
作者： Jochen Schmitz , J. Fernando Bazan , Martin Oft , Robert A. Kastelein
DOI:
关键词:
摘要: Provided are methods of modulating cytokine activity, e.g., for the purpose treating immune and inflammatory disorders, including tumors cancer. Also provided administering agonists or antagonists IL-33 receptor.
google.de 参考文章(43)
Jochen Schmitz, J. Fernando Bazan, Martin Oft, Robert A. Kastelein, Use of agonists and antagonists of interleukin-33 (il-33) ,(2005)
Shiv Pillai, Abul K. Abbas, Andrew H. Lichtman, Cellular and Molecular Immunology ,(1994)
John E. Coligan, Current Protocols in Protein Science ,(1996)
Malcolm R. Alison, The Cancer Handbook ,(2018)
John F. Thompson, Donald L. Morton, Bin B. R. Kroon, Textbook of melanoma Martin Dunitz. ,(2004)
John Ernest Sims, Sigirr dna and polypeptides ,(1998)
David Lane, Ed Harlow, Antibodies: A Laboratory Manual ,(1988)
Leslie P. Gartner, James L. Hiatt, Color Atlas of Histology ,(1987)
Herbert A. Lieberman, Martin M. Rieger, Gilbert S. Banker, Pharmaceutical Dosage Forms: Disperse Systems ,(1988)
Naoya Tsurushita, Nicholas F. Landolfi, Maximiliano Vasquez, Cary L. Queen, Humanized antibodies to γ-interferon ,(1999)